-
Medication Aids Kidneys Function in PH Patients with Heart Disease and Renal Impairment
Levosimendan, soon starting a Phase 2 study for PH-HFpEF patients, was seen to benefit the kidneys in those with cardiorenal syndrome in a Phase 3 trial.
Read more about this study here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.